4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-010708
Options or other derivatives
- Chief Legal Officer acquired 84,850 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Siegel Jolie Chief Legal Officer | 2021-02-11 | Grant or award · Stock Option (Right to Buy) | +84,850 | 84,850 | D | ||
Loading xslF345X03/doc4.xml…